Use of the site of subcutaneous insulin administration for the measurement of glucose in patients with type 1 diabetes

Diabetes Care

Volumn 33, Issue 3, 2010, Pages 595-601

  Lindpointner, Stefan ^a   Korsatko, Stefan ^a   Köhler, Gerd ^a   K̈ohler, Hans ^a   Schaller, Roland ^b   Kaidar, Ruthy ^c   Yodfat, Ofer ^c   Schaupp, Lukas ^a,b   Ellmerer, Martin ^a   Pieber, Thomas R ^a,b   Regittnig, Werner ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b JOANNEUM RESEARCH   (Austria)

^c Medingo ^*  (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; MANNITOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; GLUCOSE TOLERANCE TEST; HUMAN; INDWELLING CATHETER; INJECTION SITE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; POINT OF CARE TESTING; SUBCUTANEOUS FAT;

ADULT; BLOOD GLUCOSE; BLOOD SPECIMEN COLLECTION; CATHETERS, INDWELLING; DIABETES MELLITUS, TYPE 1; DIAGNOSTIC TECHNIQUES, ENDOCRINE; FEASIBILITY STUDIES; FEMALE; HUMANS; INFUSION PUMPS; INFUSIONS, SUBCUTANEOUS; INSULIN; MALE; MODELS, BIOLOGICAL; PROGNOSIS; TIME FACTORS;

EID: 77649247022     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-1532     Document Type: Article

References (15)

1. Daneman D. Type 1 diabetes. Lancet 2006;367:847-858
2. Shalitin S, Phillip M. The role of new technologies in treating children and adolescents with type 1 diabetes mellitus. Pediatric Diabetes 2007;8 (Suppl. 6):72-79
3. Lindpointner S, Korsatko S, Köhler G, Köhler H, Ellmerer M, Schaupp L, Pieber TR, Regittnig W. Glucose concentration at the subcutaneous site of insulin delivery: effect of variable insulin infusion rates. Abstract presented at the 2nd European Diabetes Technology and Transplantation Meeting, 27-29 January 2008, Innsbruck, Austria
4. Schaupp L, Ellmerer M, Brunner GA, Wutte A, Sendlhofer G, Trajanoski Z, Skrabal F, Pieber TR, Wach P. Direct access to interstitial fluid in adipose tissue in humans by use of open-flow microperfusion. Am J Physiol 1999;276: E401-E408
5. Trajanoski Z, Brunner GA, Schaupp L, Ellmerer M, Wach P, Pieber TR, Kotanko P, Skrabal F. Open-flow microperfusion of subcutaneous adipose tissue for on-line continuous ex vivo measurement of glucose concentration. Diabetes Care 1997; 20:1114-1121
6. Diabetes Health: Insulin Pumps Reference Guide [article online], 2008. Available from http://www.diabeteshealth.com/media/ pdfs/PRG1208/DH-Insulin- Pumps-08-09. pdf. Accessed 22 October 2009
7. Lodwig V, Heinemann L, Glucose Monitoring Study Group. Continuous glucose monitoring with glucose sensors: calibration and assessment criteria. Diabetes Technol Ther 2003;5:572-586
8. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;5: 622-628
9. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310
10. Hovorka R, Chassin LJ, Wilinska ME, Canonico V, Akwi JA, Federici MO, Massi-Benedetti M, Hutzli I, Zaugg C, Kaufmann H, Both M, Vering T, Schaller HC, Schaupp L, Bodenlenz M, Pieber TR. Closing the loop: the ADICOL experience. Diabetes Technol Ther 2004;6:307-318
11. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 2006;55:3344-3350
12. U.S. Food and Drug Administration. Summary of safety and effectiveness data: FreeStyle Navigator Continuous Glucose Monitoring System [article online], 2008. Available from http://www.accessdata.fda.gov/cdrh-docs/pdf5/P050020b.pdf. Accessed 20 June 2009
13. U.S. Food and Drug Administration. Summary of safety and effectiveness data: DexCom STS Continuous Glucose Monitoring System [article online], 2007. Available from http://www.accessdata.fda.gov/cdrh-docs/pdf5/P050012S001b. pdf. Accessed 20 June 2009
14. U.S. Food and Drug Administration. Summary of safety and effectiveness data: Guardian RT [article online], 2006. Available from http://www.accessdata. fda.gov/cdrh-docs/pdf/P980022s011b.pdf. Accessed 20 June 2009
15. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M. Continuous subcutaneous glucose monitoring in diabetic patients. Diabetes Care 2002;25:347-352